Fabry disease is a rare genetic disorder that affects the body's ability to break down a specific type of fat. The ICD-10 code for Fabry disease is E75.21. In the previous coding system, the ICD-9 code for Fabry disease was 272.7. These codes are used by healthcare professionals for accurate diagnosis and billing purposes.
Fabry disease, also known as Anderson-Fabry disease, is a rare genetic disorder that affects multiple organ systems in the body. It is classified under the ICD-10 code E75.21. The ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems, maintained by the World Health Organization (WHO). This classification system is widely used for diagnostic coding and provides a standardized way to classify and code diseases.
The ICD-10 code E75.21 specifically refers to "Fabry's disease" and helps healthcare professionals identify and document this condition accurately. This code is important for medical billing, insurance claims, and statistical analysis of disease prevalence and treatment outcomes.
In contrast, the ICD-9 code for Fabry disease is 272.7. The ICD-9 system was used prior to the implementation of ICD-10 and has been replaced by the newer classification. However, some older medical records and databases may still utilize ICD-9 codes.
Fabry disease is characterized by a deficiency or absence of the enzyme alpha-galactosidase A, which leads to the accumulation of a specific type of fat called globotriaosylceramide (Gb3) in various tissues and organs, particularly the kidneys, heart, and nervous system. This buildup of Gb3 can result in a wide range of symptoms including pain, skin rashes, gastrointestinal disturbances, kidney dysfunction, heart problems, and neurological complications.
Early diagnosis and treatment of Fabry disease are crucial to mitigate the progression of organ damage. Enzyme replacement therapy (ERT) is the mainstay of treatment, aiming to supplement the missing enzyme and reduce the accumulation of Gb3. Additionally, supportive therapies may be employed to manage specific symptoms and complications.
In conclusion, Fabry disease is classified under the ICD-10 code E75.21 and the ICD-9 code 272.7. These codes allow healthcare professionals to accurately identify and document this rare genetic disorder, facilitating proper medical management and billing processes.